Back to home
Pre-emptive daratumumab therapy
of minimal residual disease reappearance
or biochemical relapse in multiple myeloma
BioStat Sp. z o.o.
ul. Kowalczyka 17; 44-206 Rybnik
666 069 834
BioStat is responsible for data management and statistical analysis.
Send new password